The latest news and updates about NYSCF and our collaborators
The Context: CRISPR gene editing holds a great deal of promise for correcting disease-causing mutations in humans, potentially as early as during embryonic development. However, before...
The Context: 1 in 3,000 people has a genetic defect called 22q11.2 deletion syndrome, or 22q11DS, putting them at a greater risk for developing schizophrenia. However,...
The Context: Scientists know that the microbes in a mother’s gut can affect brain function in offspring, usually in response to stress, infection, or other adverse...
Top row: Drs. Raffaella Di Micco, Samantha Morris, José Ordovás-Montañés. Bottom row: Drs. Jiami Guo, David Schneider, John Tuthill New York, NY (October 20, 2020) – The...
We are pleased to share that NYSCF Senior Research Investigator Bjarki Johannesson, PhD, and Memorial Sloan Kettering Cancer Center’s Daniela Cornacchia, PhD, have received a Healthy...
The Context: Scientists now understand the symptoms of COVID-19 fairly well, but there are still many unknowns about what happens to cells that are infected by...
At the end of August, 39 high school students who attend different public, private, and charter schools across New York City and the Northeast and hail...
The Context: Organoids – 3D structures of human tissue derived from stem cells – are a critical tool for helping researchers study diseases like cancer and...
The Context: Many drugs cause liver injury in certain patients, and this is a leading cause of acute liver failure in the United States. A major...
It has been six months since the COVID-19 pandemic hit the United States at full force, leaving millions sick, out of work, and desperate for new...
A multi-institutional team of scientists led by Lorenz Studer, MD (Memorial Sloan Kettering Cancer Center) and including Gist Croft, PhD (The NYSCF Research Institute), NYSCF –...
“Incredible.” “Eclectic.” “Life-changing.” These are just a few words that the 2020 class of NYSCF interns have used to describe their summer. These 22 talented high...
The Context: Mitochondria are structures in our cells that carry their own DNA inherited only from our mothers and provide energy to help our bodies function....
Today, more than 6 million Americans suffer from neurodegenerative diseases such as Parkinson’s, Alzheimer’s, and multiple sclerosis, and as our society ages, that number is only...
The Context: Several infectious diseases such as Zika, dengue, yellow fever, and Chikungunya virus are transmissible through mosquito bites. Not all types of mosquitoes bite humans,...
The Context: While scientists suspect that goosebumps help animals with fur stay warm in cold environments, the reason that humans get goosebumps has been unclear. The...
At Lili Barbar’s final lab meeting (which per a discussion with her team, was pajama-themed), her mentor Valentina Fossati, PhD, began by expressing how much Lili...
“We just have to keep at it [with gender inequity in science and medicine],” remarked NYSCF CEO Susan L. Solomon. “We have to keep trying to...
The Context: One of the most useful ways for brain researchers to observe the activity of neurons is through a technique called calcium imaging, but current...
The Context: Pelizaeus-Merzbacher disease (PMD) is a rare genetic disorder that affects myelin, the ‘cable insulation’ that helps neurons send signals, leading to severe muscle stiffness...
The Context: Approximately 48 million Americans have some degree of hearing loss, largely due to damage of hair cells in the ears that make hearing possible....
Disease impacts everyone, but not in the same way. Disease risk and drug efficacy can vary a great deal across individuals, and unfortunately, much of what...
By Paul Goldberger, NYSCF Board Member The artist Christo, a longtime supporter of NYSCF, died on May 31. The New York Stem Cell Foundation mourns the...
NYSCF CEO Susan L. Solomon recently received the 2020 Public Service Award from the International Society for Stem Cell Research (ISSCR) for her outstanding contributions to...
Ovarian cancer is a difficult disease to tackle, as is evident from the statistics that surround it: Five years after diagnosis, ovarian cancer survival rates are...
